Acronym Definition; ELCAP: Early Lung Cancer Action Program: ELCAP: Evangelical Lutheran Church AIDS Programme (Namibia). Survival of patients with stage I lung cancer detected on CT screening. International Early Lung Cancer Action Program. Research from JAMA Internal Medicine — Overstating the Evidence for Lung Cancer Screening — The International Early Lung Cancer Action Program (I-ELCAP) Study. In a large collaborative study the International Early Lung Cancer Action Program Investigators screened 31 567 asymptomatic persons at risk for lung cancer with. Annual CT Screening Detects Early- stage Lung Cancers, Saves Lives - - Science. Daily. New York, NY - - Annual computed tomography (CT) screening is an effective diagnostic tool for detecting early- stage lung cancer in smokers and for reducing mortality rates, according to the latest data from two ongoing studies. The new findings, which confirm earlier published studies, were presented by Dr. Claudia henschke of New York- Presbyterian Hospital/Weill Cornell Medical Center, at the 8. Radiological Society of North America (RSNA) in Chicago earlier this month. Henschke is principal investigator of the two studies - - the Early Lung Cancer Action Program (ELCAP), the first major study of low- dose CT creening in smokers and former smokers age 6. NY- ELCAP, a collaboration between 1. New York- based medical centers that are investigating annual CT screenings. ![]() Our events include the semi-annual International Conference on Screening for Lung Cancer, and CME training courses on CT screening for lung cancer and. Henschke, Professor of Radiology at Weill Cornell Medical College and Division Chief of Chest Imaging and Attending Radiologist at New. York- Presbyterian Hospital/Weill Cornell. The ELCAP results from the first, baseline screening were published in the July 1. Lancet, demonstrating that low- dose CT can detect lung cancer at an earlier, more curable stage than ordinary chest x- ray. The results of annual repeat screening, published in the July 1, 2. Cancer, also confirmed that with repeated annual CT screenings, 8. The NY- ELCAP study confirmed the ELCAP findings, both for the baseline and annual repeat screenings. Henschke. Lung cancer is the leading cause of cancer death among men and women, and more people will die of lung cancer than of breast, colon and prostate cancers combined, according to the American Cancer Society. Lung cancer has no early warning signs and, for that reason, it is often detected at a late stage, at which time tumors may be the size of an apple. Late- stage symptoms include shortness of breath, hoarseness, coughing up blood, and unexplained weight loss. ELCAPSince its start in 1. ELCAP has administered 4,5. Among the 2. 9 cancers found, 9. Stage I, indicating that annual screening was frequent enough to diagnose early- stage lung cancer. The study also looked at the long- term follow- up of patients with screen- diagnosed lung cancer who underwent surgery and found that they showed a high cure rate. Co- authors are Dr. David Yankelevitz, Professor of Radiology at Weill Cornell Medical College and Attending Radiologist at New. York- Presbyterian Hospital/Weill Cornell; Dr. Mc. Cauley, Professor of Radiology at Weill Cornell Medical College and Attending Radiologist at New. York- Presbyterian Hospital/Weill Cornell; Dr. Kostis, Assistant Professor of Radiology at Weill Cornell Medical College and Assistant Attending Radiologist at New. York- Presbyterian Hospital/Weill Cornell; and O. Farooqi, Radiology Fellow, Weill Cornell Medical College. The ELCAP study was partially funded by the National Cancer Institute, GE, and Kodak. NY- ELCAPThe effectiveness of annual CT screening in high- risk subjects was evaluated at 1. New York. Participants - - 6,3. CT scan of the lungs and chest. As of November 2. CT screenings have been performed on 4,6. Both in the first, baseline screening and in the subsequent, annual repeat screening, more than 8. Stage I, confirming the initial results of ELCAP. The average survival rate for patients treated for Stage I lung cancer is about 7. Stage II and later - - is about 5 percent, according to Dr. Henschke. Co- authors of the study were Dr. Matthew Rifkin of the State University of New York at Stony Brook; Dr.
Samuel Kopel of Maimonides Medical Center; Dr. Klippenstein of Roswell Park Cancer Insitute; Dr. Arfa Khan of North- Shore- Long Island Jewish Health System; Dr. Kohman of State University of New York, Upstate Medical Center; Dr. John Austin of Columbia University College of Physicians & Surgeons; Dr. Mendelson of Mount Sinai School of Medicine; Dr. Robert Heelan of Memorial Sloan- Kettering Cancer Center; Dr. Terence Matalon of New York Medical College; Peter H. Wiernik of Our Lady of Mercy Medical Center; and Dr. Gordon of State University of New York, Downstate Medical Center. NY- ELCAP evolved from the ELCAP study, created in 1. New. York- Presbyterian Hospital/Weill Cornell Medical Center and New York University Medical Center. NY- ELCAP is funded by the Academic Medicine Development Company (AMDe. ![]() C), which was created in 1. Radiological Society of North America. RSNA is an association of more than 3. The Society is based in Oak Brook, Ill. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2017
Categories |